Cerebral Hypoxia Clinical Trials

Find Cerebral Hypoxia Clinical Trials Near You

Transoral Nasal Cannula Oxygen Delivery on Postoperative Hypoxemia for Mouth-breathing Patients After Surgery: a Randomized Controlled Crossover Trial

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Postoperative hypoxemia is a common complication in the postanesthesia care unit (PACU). Patients who breathe through the mouth after tracheal extubation may receive limited benefit from standard nasal cannula oxygen therapy, because the nasal cavity functions as an ineffective dead space during mouth breathing. Clinical observations suggest that placing the prongs of a nasal cannula inside the mouth (transoral oxygen delivery) rapidly improves oxygenation in these patients. However, no randomized controlled trial has formally verified this effect. This single-center, randomized, controlled, crossover trial will enroll 64 adult patients identified as persistent mouth breathers after extubation in the PACU following elective thoracic or abdominal surgery under general anesthesia. Each participant will receive, in a randomized sequence, both standard nasal cannula oxygen delivery (4 L/min for 10 minutes) and transoral nasal cannula oxygen delivery (4 L/min for 10 minutes), separated by a 5-minute washout period, so that each participant serves as his or her own control. The primary outcome is the incidence of hypoxemia (peripheral oxygen saturation \[SpO2\] \<90% sustained for at least 10 seconds, or oxygenation index \[PaO2/FiO2 ratio\] \<300 mmHg) during each oxygen delivery period. Secondary outcomes include the incidence of SpO2 \<92%, time to achieve SpO2 \>=95%, oxygenation index measured by arterial blood gas analysis, need for escalation of oxygen therapy, vital signs, patient comfort and adverse effects, PACU length of stay, and respiratory complications within 24 hours after surgery. The results are expected to provide high-level evidence for optimizing oxygen therapy strategies for mouth-breathing patients in the PACU.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Aged older than 18 years;

• American Society of Anesthesiologists (ASA) physical status classification I-III;

• Undergoing elective thoracic or abdominal surgery under general anesthesia with postoperative transfer to the postanesthesia care unit (PACU);

• Anticipated PACU stay of at least 30 minutes to allow an adequate observation window for data collection;

• Recovery of spontaneous breathing after tracheal extubation, and confirmed as persistent mouth breathing by the standardized three-step assessment procedure (visual screening, cotton-fiber airflow verification, and mirror confirmation);

• Written informed consent signed by the patient or a family member.

Locations
Other Locations
China
Nanjing First Hospital, Nanjing Medical University
RECRUITING
Nanjing
Contact Information
Primary
Shuai Wang
wangshuaisj@126.com
+8618852095101
Backup
YING ZHANG
025-52271064
Time Frame
Start Date: 2026-10-08
Estimated Completion Date: 2027-12-31
Participants
Target number of participants: 64
Treatments
Active_comparator: Sequence ON: Transoral oxygen first, then nasal oxygen
Participants receive transoral nasal cannula oxygen delivery (4 L/min for 10 minutes), followed by a 5-minute washout period (nasal oxygen delivery resumed), and then standard nasal cannula oxygen delivery (4 L/min for 10 minutes).
Active_comparator: Sequence NO: Nasal oxygen first, then transoral oxygen
Participants receive standard nasal cannula oxygen delivery (4 L/min for 10 minutes), followed by a 5-minute washout period (nasal oxygen delivery resumed), and then transoral nasal cannula oxygen delivery (4 L/min for 10 minutes).
Related Therapeutic Areas
Sponsors
Leads: Nanjing First Hospital, Nanjing Medical University

This content was sourced from clinicaltrials.gov

Similar Clinical Trials